3-羟基嘧啶-2,4-二酮作为 HIV 整合酶抑制剂的骨架。
3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase.
机构信息
Center for Drug Design, Academic Health Center, University of Minnesota, Minneapolis, Minnesota 55455, United States.
出版信息
J Med Chem. 2011 Apr 14;54(7):2282-92. doi: 10.1021/jm1014378. Epub 2011 Mar 7.
Abstract
Integrase (IN) represents a clinically validated target for the development of antivirals against human immunodeficiency virus (HIV). Inhibitors with a novel structure core are essential for combating resistance associated with known IN inhibitors (INIs). We have previously disclosed a novel dual inhibitor scaffold of HIV IN and reverse transcriptase (RT). Here we report the complete structure-activity relationship (SAR), molecular modeling, and resistance profile of this inhibitor type on IN inhibition. These studies support an antiviral mechanism of dual inhibition against both IN and RT and validate 3-hydroxypyrimidine-2,4-diones as an IN inhibitor scaffold.
摘要
整合酶 (IN) 是临床验证的抗人类免疫缺陷病毒 (HIV) 抗病毒药物开发的靶标。具有新型结构核心的抑制剂对于对抗与已知整合酶抑制剂 (INIs) 相关的耐药性至关重要。我们之前已经披露了 HIV IN 和逆转录酶 (RT) 的新型双重抑制剂支架。在这里，我们报告了这种抑制剂类型对 IN 抑制的完整结构-活性关系 (SAR)、分子建模和耐药性特征。这些研究支持了针对 IN 和 RT 的双重抑制的抗病毒机制，并验证了 3-羟基嘧啶-2,4-二酮作为 IN 抑制剂支架。
相似文献
1
3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase.3-羟基嘧啶-2,4-二酮作为 HIV 整合酶抑制剂的骨架。
J Med Chem. 2011 Apr 14;54(7):2282-92. doi: 10.1021/jm1014378. Epub 2011 Mar 7.
2
6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.6-苯甲酰基-3-羟基嘧啶-2,4-二酮作为 HIV 逆转录酶和整合酶的双重抑制剂。
Bioorg Med Chem Lett. 2011 Apr 15;21(8):2400-2. doi: 10.1016/j.bmcl.2011.02.069. Epub 2011 Feb 18.
3
Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: selection of the scaffold.设计一系列二环 HIV-1 整合酶抑制剂。第 1 部分：支架的选择。
Bioorg Med Chem Lett. 2010 Oct 1;20(19):5913-7. doi: 10.1016/j.bmcl.2010.07.079. Epub 2010 Jul 27.
4
Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.HIV 逆转录酶和整合酶双重抑制剂骨架内整合酶抑制作用的药效团和结构活性关系。
Bioorg Med Chem. 2010 Jun 15;18(12):4202-11. doi: 10.1016/j.bmc.2010.05.004. Epub 2010 May 7.
5
Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase.HIV-1整合酶的5-羟基-6-氧代-1,6-二氢嘧啶-4-甲酰胺抑制剂的设计与发现
Bioorg Med Chem. 2014 Oct 1;22(19):5446-53. doi: 10.1016/j.bmc.2014.07.036. Epub 2014 Jul 30.
6
Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors.新型 C2-吡唑并嘧啶酰胺和酰胺类变构整合酶抑制剂的设计、合成及构效关系研究。
Bioorg Med Chem Lett. 2020 Nov 1;30(21):127516. doi: 10.1016/j.bmcl.2020.127516. Epub 2020 Aug 27.
7
Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.喹喔啉二酮酸衍生物的合成、生物评价及分子模拟研究：HIV-1 整合酶抑制作用的新结构见解。
Eur J Med Chem. 2011 May;46(5):1749-56. doi: 10.1016/j.ejmech.2011.02.028. Epub 2011 Feb 22.
8
The discovery and preclinical evaluation of BMS-707035, a potent HIV-1 integrase strand transfer inhibitor.强效HIV-1整合酶链转移抑制剂BMS-707035的发现与临床前评估
Bioorg Med Chem Lett. 2018 Jul 1;28(12):2124-2130. doi: 10.1016/j.bmcl.2018.05.027. Epub 2018 May 14.
9
A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.一种用于设计HIV整合酶抑制剂的平台。第1部分：2-羟基-3-杂芳基丙烯酸衍生物作为新型HIV整合酶抑制剂及亲水和疏水药效团的建模。
Bioorg Med Chem. 2006 Dec 15;14(24):8430-45. doi: 10.1016/j.bmc.2006.08.044. Epub 2006 Sep 28.
10
HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent.具有核碱基支架的HIV整合酶抑制剂：一种高效抗HIV药物的发现
J Med Chem. 2006 Jan 26;49(2):445-7. doi: 10.1021/jm0508890.
引用本文的文献
1
Inhibiting HCMV pUL89-C Endonuclease with Metal-Binding Compounds.用金属结合化合物抑制 HCMV pUL89-C 内切酶。
J Med Chem. 2023 Oct 26;66(20):13874-13887. doi: 10.1021/acs.jmedchem.3c01280. Epub 2023 Oct 12.
2
Repurposing N-hydroxy thienopyrimidine-2,4-diones (HtPD) as inhibitors of human cytomegalovirus pUL89 endonuclease: Synthesis and biological characterization.将 N-羟基噻吩并嘧啶-2,4-二酮（HtPD）重新用作人巨细胞病毒 pUL89 内切酶抑制剂：合成与生物学特性。
Bioorg Chem. 2022 Dec;129:106198. doi: 10.1016/j.bioorg.2022.106198. Epub 2022 Oct 12.
3
8-Hydroxy-1,6-naphthyridine-7-carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.8-羟基-1,6-萘啶-7-甲酰胺作为人巨细胞病毒 pUL89 内切酶抑制剂。
ChemMedChem. 2022 Sep 5;17(17):e202200334. doi: 10.1002/cmdc.202200334. Epub 2022 Aug 10.
4
4,5-Dihydroxypyrimidine Methyl Carboxylates, Carboxylic Acids, and Carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.4,5-二羟嘧啶甲酯、羧酸和羧酰胺作为人巨细胞病毒 pUL89 内切酶抑制剂。
J Med Chem. 2022 Apr 14;65(7):5830-5849. doi: 10.1021/acs.jmedchem.2c00203. Epub 2022 Apr 4.
5
Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.设计、合成及二聚化苯丙氨酸衍生物作为新型 HIV-1 衣壳抑制剂的作用机制研究。
Eur J Med Chem. 2021 Dec 15;226:113848. doi: 10.1016/j.ejmech.2021.113848. Epub 2021 Sep 16.
6
HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies.HIV-1逆转录酶/整合酶双重抑制剂：近期进展及构效关系研究综述
Iran J Pharm Res. 2021 Spring;20(2):333-369. doi: 10.22037/ijpr.2021.115446.15370.
7
Metal binding 6-arylthio-3-hydroxypyrimidine-2,4-diones inhibited human cytomegalovirus by targeting the pUL89 endonuclease of the terminase complex.金属结合 6-芳基硫代-3-羟基嘧啶-2,4-二酮通过靶向末端酶复合物的 pUL89 内切酶抑制人巨细胞病毒。
Eur J Med Chem. 2021 Oct 15;222:113640. doi: 10.1016/j.ejmech.2021.113640. Epub 2021 Jun 12.
8
Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.切入基质优势：基于药效团和结构的方法抑制人类免疫缺陷病毒逆转录酶相关核糖核酸酶 H。
Acc Chem Res. 2020 Jan 21;53(1):218-230. doi: 10.1021/acs.accounts.9b00450. Epub 2019 Dec 27.
9
6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H.6-联苯甲基-3-羟基嘧啶-2,4-二酮能强烈且选择性地抑制 HIV 逆转录酶相关的核糖核酸酶 H。
Eur J Med Chem. 2018 Aug 5;156:680-691. doi: 10.1016/j.ejmech.2018.07.035. Epub 2018 Jul 17.
10
Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity.双翼3-羟基嘧啶-2,4-二酮：对HIV-1核糖核酸酶H具有强效且选择性抑制作用，并具有显著抗病毒活性
J Med Chem. 2017 Jun 22;60(12):5045-5056. doi: 10.1021/acs.jmedchem.7b00440. Epub 2017 May 31.
本文引用的文献
1
N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase.嘧啶-2,4-二酮的N-3羟基化产生HIV逆转录酶和整合酶的双重抑制剂。
ACS Med Chem Lett. 2011 Jan;2(1):63-67. doi: 10.1021/ml1002162.
2
Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance.逆转录酶抑制剂的分子机制与病毒耐药性的进化。
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20057-62. doi: 10.1073/pnas.1010246107. Epub 2010 Oct 28.
3
Structure-based modeling of the functional HIV-1 intasome and its inhibition.基于结构的功能性 HIV-1 整合酶三聚体模型及其抑制作用。
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15910-5. doi: 10.1073/pnas.1002346107. Epub 2010 Aug 23.
4
Novel integrase inhibitors for HIV.新型 HIV 整合酶抑制剂。
Expert Opin Investig Drugs. 2010 Sep;19(9):1087-98. doi: 10.1517/13543784.2010.501078.
5
Resistance to integrase inhibitors.对整合酶抑制剂的耐药性。
Viruses. 2010 Jun 25;2(7):1347-66. doi: 10.3390/v2071347.
6
Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.小分子抑制剂的理性设计 LEDGF/p75-整合酶相互作用和 HIV 复制。
Nat Chem Biol. 2010 Jun;6(6):442-8. doi: 10.1038/nchembio.370. Epub 2010 May 16.
7
Scaffold rearrangement of dihydroxypyrimidine inhibitors of HIV integrase: Docking model revisited.二羟嘧啶类 HIV 整合酶抑制剂的支架重排：对接模型再探讨。
Bioorg Med Chem Lett. 2010 Jun 1;20(11):3275-9. doi: 10.1016/j.bmcl.2010.04.048. Epub 2010 Apr 21.
8
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens.拉替拉韦治疗失败的经治患者中整合酶抑制剂耐药模式与 HIV-1。
J Antimicrob Chemother. 2010 Jun;65(6):1262-9. doi: 10.1093/jac/dkq099. Epub 2010 Apr 12.
9
Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir.抗雷特格韦的 HIV-1 整合酶柔性环突变体的生化和药理学分析。
Biochemistry. 2010 May 4;49(17):3715-22. doi: 10.1021/bi100130f.
10
Retroviral intasome assembly and inhibition of DNA strand transfer.逆转录病毒内切体组装和 DNA 链转移抑制。
Nature. 2010 Mar 11;464(7286):232-6. doi: 10.1038/nature08784. Epub 2010 Jan 31.
Zotero 插件